Atritech (Plymouth, MN) a clinical-stage medical device company focused on developing minimally invasive technologies designed for the prevention of atrial fibrillation related stroke, closed a $30M Series E financing. Participants include Thomas, McNerney & Partners, Split Rock Partners, Prism VentureWorks, Tullis-Dickerson and Vector Group.